Cargando…

Digitoxin activates EGR1 and synergizes with paclitaxel on human breast cancer cells

BACKGROUND: Numerous studies have suggested that digitalis derivatives promise to be superior to existing adjuvant therapy for breast cancer as to effects and side-effects. In the present study, we have used gene expression analysis to determine the molecular action of digitoxin on breast cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einbond, Linda Saxe, Wu, Hsan-au, Su, Tao, Chang, Tangel, Panjikaran, Maya, Wang, Xiaomei, Goldsberry, Sarah
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997271/ https://www.ncbi.nlm.nih.gov/pubmed/21139994 http://dx.doi.org/10.4103/1477-3163.72578

Ejemplares similares

Digitoxin—A Critical Review
por: Diefenbach, William C., et al.
Publicado: (1949)

A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA
por: Einbond, Linda Saxe, et al.
Publicado: (2020)

Digitoxin and its analogs as novel cancer therapeutics
por: Elbaz, Hosam A, et al.
Publicado: (2012)

Accidental digitoxin intoxication: an interplay between laboratory and clinical medicine
por: Castello, Luigi M, et al.
Publicado: (2012)

Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel
por: YAKISICH, JUAN SEBASTIAN, et al.
Publicado: (2016)

Digitoxin medication and cancer; case control and internal dose-response studies
por: Haux, Johan, et al.
Publicado: (2001)

Digitoxin Inhibits Epithelial-to-Mesenchymal-Transition in Hereditary Castration Resistant Prostate Cancer
por: Pollard, Bette S., et al.
Publicado: (2019)

Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial
por: Bavendiek, Udo, et al.
Publicado: (2023)

The inotropic agent digitoxin strengthens desmosomal adhesion in cardiac myocytes in an ERK1/2-dependent manner
por: Schinner, Camilla, et al.
Publicado: (2020)

Inhibitory Effects of Digoxin and Digitoxin on Cell Growth in Human Ovarian Cancer Cell Line SKOV-3
por: Chou, Jou-Chun, et al.
Publicado: (2021)

Digitoxin Affects Metabolism, ROS Production and Proliferation in Pancreatic Cancer Cells Differently Depending on the Cell Phenotype
por: Lindholm, Heléne, et al.
Publicado: (2022)

Digitoxin induces apoptosis in cancer cells by inhibiting nuclear factor of activated T-cells-driven c-MYC expression
por: Yang, Qing Feng, et al.
Publicado: (2013)

Na+/K+‑ATPase subunit α3 expression is associated with the efficacy of digitoxin treatment in pancreatic cancer cells
por: Lindholm, Heléne, et al.
Publicado: (2022)

Egr2 and Egr3 are the unique regulators for systemic autoimmunity
por: Sumitomo, Shuji, et al.
Publicado: (2013)

In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis
por: Freitas, Camila S., et al.
Publicado: (2021)

Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
por: Scharer, Christopher D, et al.
Publicado: (2008)

E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines
por: Kurtyka, Courtney A., et al.
Publicado: (2014)

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
por: Gong, Li-Hua, et al.
Publicado: (2014)

Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro
por: Xia, Xuan, et al.
Publicado: (2023)

MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
por: Wirth, Matthias, et al.
Publicado: (2014)

Digitoxin inhibits proliferation of multidrug-resistant HepG2 cells through G(2)/M cell cycle arrest and apoptosis
por: Lei, Yuhe, et al.
Publicado: (2020)

Characterization of Induced Pluripotent Stem Cell Microvesicle Genesis, Morphology and Pluripotent Content
por: Zhou, Jing, et al.
Publicado: (2016)

Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2020)

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
por: Shin, Sol-Bi, et al.
Publicado: (2020)

Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
por: Le Large, T. Y. S., et al.
Publicado: (2021)

TRAIL and Paclitaxel Synergize to Kill U87 Cells and U87-Derived Stem-Like Cells in Vitro
por: Qiu, Bo, et al.
Publicado: (2012)

The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation
por: Boyle, Keith B., et al.
Publicado: (2009)

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
por: Ingemarsdotter, C K, et al.
Publicado: (2010)

Prognostic role of EGR1 in breast cancer: a systematic review
por: Saha, Subbroto Kumar, et al.
Publicado: (2021)

Paradoxical Role of an Egr Transcription Factor Family Member, Egr2/Krox20, in Learning and Memory
por: Poirier, Roseline, et al.
Publicado: (2007)

Development of a new ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for the determination of digoxin and digitoxin in plasma: Comparison with a clinical immunoassay
por: Ballotari, Marco, et al.
Publicado: (2022)

The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells
por: Xu, Yuanyuan, et al.
Publicado: (2016)

Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies
por: Müller, Fabian, et al.
Publicado: (2017)

1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel
por: Modi, Karan, et al.
Publicado: (2020)

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2017)

Egr-2 prevents self-reactions
por: Bashyam, Hema
Publicado: (2008)

Elevated and sustained Egr1 and Egr2 expression controls NKT lineage differentiation in response to TCR signaling
por: Seiler, Michael P., et al.
Publicado: (2012)

The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells
por: Li, Suling, et al.
Publicado: (2012)

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
por: Bavendiek, Udo, et al.
Publicado: (2019)

Awareness of predatory publishing
por: Panjikaran, Lloyd, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0hkhc3rsba8f8hqvl3h84rfnes